PROSPECTUS  Pricing Supplement No. 4270 
Dated May 17, 2005  Dated December 15, 2005 
PROSPECTUS SUPPLEMENT  Rule 424(b)(3)-Registration Statement 
Dated August 24, 2005  No. 333-123085 

GENERAL ELECTRIC CAPITAL CORPORATION
GLOBAL MEDIUM-TERM NOTES, SERIES A
(Floating Rate Notes)
   
Issuer:  General Electric Capital Corporation 
   
Ratings:  Aaa/AAA 
   
Trade Date:  December 15, 2005 
   
Settlement Date (Original Issue Date):       January 5, 2006 
   
Maturity Date:  January 5, 2009 
   
Principal Amount:  U.S.$ 1,000,000,000 
   
Price to Public (Issue Price):  100.00% 
   
Agent's Commission:  0.150% 
   
All-in Price:  99.85% 
   
Accrued Interest:  None 
   
Net Proceeds to Issue:  U.S.$ 998,500,000 
   
Interest Rate Basis:  LIBOR, as determined by LIBOR Telerate 
   
Index Currency:  U.S. Dollars 
   
Spread (Plus or Minus)  Plus 0.04% 
   
Index Maturity:  Three Months 
   
Interest Payment Period:  Quarterly 
   
Interest Payment Dates:  Quarterly on each April 5, July 5, October 5, and January 5, ending on the 
  Maturity Date 
   
Initial Interest Rate:  To be determined two London Business Days prior to the Original Issue 
  Date based on three month USD LIBOR plus 0.04% 
   
Interest Reset Periods and Dates:  Quarterly on each Interest Payment Date 
   
Interest Determination Dates:  Quarterly, two London Business Days prior to each Interest Reset Date 
   
Day Count Convention:  Actual/360 
   
Denominations:  Minimum of $1,000 with increments of $1,000 thereafter 
   
Redemption Dates:  None 
   
Put Dates:  None 
   
Settlement:  DTC 
   
CUSIP:  36962GT79 


  (Floating Rate) 
  Page 2 
  Pricing Supplement No. 4270 
  Dated December 15, 2005 
  Rule 424(b)(3)-Registration Statement 
  No. 333-123085 

Additional Information:

Reopening of Issue:

The Notes are intended to be fully fungible and be consolidated and form a single issue for all purposes with the company's issue of US$ 1,000,000,000 Floating Rate Notes due January 5, 2009 as described in the company's pricing supplement number 4269 dated December 12, 2005.

General
At September 30, 2005, the Company had outstanding indebtedness totaling $344.022 billion, consisting of notes payable within one year, senior notes payable after one year and subordinated notes payable after one year. The total amount of outstanding indebtedness at September 30, 2005, excluding subordinated notes payable after one year was equal to $341.143 billion.

Consolidated Ratio of Earnings to Fixed Charges
The information contained in the Prospectus under the caption “Consolidated Ratio of Earnings to Fixed Charges” is hereby amended in its entirety, as follows:

    Year Ended December 31,      Nine Months Ended 
2000 
2001  2002  2003  2004  September 30, 2005 
(Restated)  (Restated)  (Restated)  (Restated)   
1.52 
1.73  1.66  1.86  1.89  1.82 

For purposes of computing the consolidated ratio of earnings to fixed charges, earnings consist of net earnings adjusted for the provision for income taxes, minority interest and fixed charges. Fixed charges consist of interest and discount on all indebtedness and one-third of rentals, which the Company believes is a reasonable approximation of the interest factor of such rentals.

Plan of Distribution:

The Notes are being purchased by the following financial institutions in their respective amounts (collectively, the “Underwriters”), as principal, at 100% of the aggregate principal amount less an underwriting discount equal to 0.15 % of the principal amount of the Notes.

Institution 
          Commitment 
Lead Managers:   
 
Merrill Lynch, Pierce, Fenner &  $400,000,000 
Smith Incorporated   
Barclays Capital Inc.  $400,000,000 
 
Co-Manager:   
Bank of America Securities LLC                 $200,000,000 
 
Total  $1,000,000,000 

The Company has agreed to indemnify the Underwriters against certain liabilities, including liabilities under the Securities Act of 1933, as amended.

CAPITALIZED TERMS USED HEREIN WHICH ARE DEFINED IN THE PROSPECTUS SUPPLEMENT SHALL HAVE THE MEANINGS ASSIGNED TO THEM IN THE PROSPECTUS SUPPLEMENT.